TMDX
TransMedics Group Inc
NASDAQ: TMDX · HEALTHCARE · MEDICAL DEVICES
$98.57
-2.66% today
Updated 2026-04-29
Market cap
$3.41B
P/E ratio
20.24
P/S ratio
5.62x
EPS (TTM)
$4.87
Dividend yield
—
52W range
$89 – $156
Volume
1.0M
TransMedics Group Inc (TMDX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
31.40%
Operating margin
13.20%
ROE
54.20%
ROA
7.25%
Debt/equity
1.46x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-17.55M | — | — | — |
| 2016 | $6.21M | $-24.07M | 12.34% | -370.20% | -387.58% |
| 2017 | $7.68M | $-20.82M | 27.81% | -265.79% | -270.96% |
| 2018 | $13.02M | $-23.76M | 44.05% | -155.47% | -182.50% |
| 2019 | $23.60M | $-33.55M | 58.73% | -125.42% | -142.12% |
| 2020 | $25.64M | $-28.75M | 64.88% | -102.91% | -112.13% |
| 2021 | $30.26M | $-44.22M | 69.92% | -130.29% | -146.11% |
| 2022 | $93.46M | $-36.23M | 69.84% | -33.64% | -38.77% |
| 2023 | $241.62M | $-25.03M | 63.77% | -11.89% | -10.36% |
| 2024 | $441.54M | $35.46M | 59.36% | 8.49% | 8.03% |
| 2025 | $605.49M | $190.29M | 59.92% | 17.93% | 31.43% |